| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MLYS | Common Stock | Award | $22.6M | +1.67M | +127.55% | $13.50 | 2.98M | Feb 12, 2024 | See footnote | F1, F2 |
| holding | MLYS | Common Stock | 1.87M | Feb 12, 2024 | See Footnote | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MLYS | Pre-Funded Warrants (Right to Buy) | Award | $7.42M | +550K | $13.50 | 550K | Feb 12, 2024 | Common Stock | 550K | $0.00 | See Footnote | F1, F2, F4 |
| Id | Content |
|---|---|
| F1 | These securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund"). |
| F2 | RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus III Fund, L.P. (the "Nexus Fund III"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. |
| F3 | These securities are held directly by the Nexus Fund III. |
| F4 | The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. The Fund may not exercise the Pre-Funded Warrants to the extent that, following exercise, the Fund, together with its affiliates and other attribution parties, would own more than 9.99% of the Common Stock outstanding. |
Derek DiRocco, a Partner of the Adviser, serves on the Issuer's board of directors.